Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
428.95
-3.64 (-0.84%)
May 13, 2025, 4:00 PM - Market closed
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.36B in the quarter ending March 29, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to $42.90B, up 0.96% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$42.90B
Revenue Growth
+0.96%
P/S Ratio
3.81
Revenue / Employee
$343,184
Employees
125,000
Market Cap
161.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
TMO News
- 13 hours ago - Thermo Fisher Scientific Inc. (TMO) BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha
- 1 day ago - Thermo Fisher: Tariffs Hit, Valuation Compensates - Seeking Alpha
- 7 days ago - 10 Undervalued Dividend Growth Stocks: May 2025 - Seeking Alpha
- 8 days ago - Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13 - Business Wire
- 14 days ago - 3 Of The Cheapest High-Quality Stocks Money Can Buy - Seeking Alpha
- 14 days ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 16 days ago - Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics - Business Wire
- 19 days ago - Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan - Benzinga